Intersect ENT (XENT) Tops Q4 EPS by 5c

Intersect ENT (NASDAQ: XENT) reported Q4 EPS of ($0.20), $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $18.36 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23